Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Best Buy Co Inc (BBY) vs 10X Genomics Inc (TXG) Price & Performance

Best Buy Co IncTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Best Buy Co Inc vs 10X Genomics Inc — how do they compare? Best Buy Co Inc trades at $83.25 (market cap $17.55B), while 10X Genomics Inc trades at $58.6 (market cap $7.61B). The key difference: Best Buy Co Inc is far larger — about 2.3× 10X Genomics Inc's market cap, and Best Buy Co Inc pays a 4.61% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.

BBYTXG
Market Cap
$17.55B$7.61B
Sector
Consumer CyclicalHealth
52-Week High
$90.17$58.57
52-Week Low
$55.52$11.34
Enterprise Value
$19.93B$7.14B
Dividend Yield
4.61%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Best Buy Co Inc

BBY trades at $82.43, up 0.52% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 39.1% ROE and trades at a P/E of 15.42, below the sector average. Recent news includes leadership changes and store format tests aimed at growth.

Outlook is mixed: analyst consensus is a hold with a $84.31 price target, but risks include declining revenue and competitive pressures. Upside potential exists if new strategies boost sales, while downside is capped by solid cash flow and dividend payments.

10X Genomics Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Best Buy Co Inc

With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.

Read more on BBY

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG